Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

Delayed Data
As of Jun 29
 +0.1975 / +0.97%
Today’s Change
Today|||52-Week Range
These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains
Jun 29 / MotleyFool.com - Paid Partner Content
Mylan Launches Generic Version of Glaxo's Avodart in U.S.
Jun 27 / Zacks.com - Paid Partner Content
New Stock Research Reports for June 28, 2016
Jun 28 / Zacks.com - Paid Partner Content
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content
Shire and Glaxo Offer Prescription to London's Woes
Jun 28 / TheStreet.com - Paid Partner Content
GlaxoSmithKline (GSK) Flagged As Today's Pre-Market Laggard
Jun 27 / TheStreet.com - Paid Partner Content
Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals
Jun 28 / MotleyFool.com - Paid Partner Content
Post-Brexit Analysis: Should Investors Buy or Sell Biopharma?
Jun 24 / MotleyFool.com - Paid Partner Content
Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?
Jun 27 / MotleyFool.com - Paid Partner Content
Jeff Auxier Sells Precision Castparts, AT&T, Microsoft
Jun 23 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close20.41
Today’s open20.65
Day’s range20.61 - 20.65
Average volume (3 months)16,380
Market cap$99.4B
Dividend yield5.96%
Data as of 10:46am ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--


Health Technology
Pharmaceuticals: Major
No executives to display
Corporate headquarters
--, --


Partner Offers

Search for Jobs